Home > Category > Signaling Pathways > Stem Cells & Wnt > Wnt/β-catenin > Vantictumab (Anti-FZD)

Vantictumab (Anti-FZD)

ChemLeader 95+%

Catalog No：CLA1337 CAS No.：1345009-45-1 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$800.00	Visible after login	- +
5 mg	3-5days	$2300.00	Visible after login	- +
10 mg	3-5days	$4200.00	Visible after login	- +
50 mg	3-5days	$18500.00	Visible after login	- +
100 mg	3-5days	$34000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Vantictumab (Anti-FZD)
CAS	1345009-45-1
Storage condition	Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.

Product details

Vantictumab (Anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. MW: 145.5 KD.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1337

Vantictumab (Anti-FZD)

1345009-45-1 95+%